HAEMOPRESSIN 1 mg, powder and solvent for solution for injection 5 bottles of 5 ml
Active ingredients: Terlipressin acetate, Terlipressin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for solution for injection5 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HAEMOPRESSIN 1 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre - 5 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- ALLIANCE PHARMA (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66180816CIP75753721CIP133400957537210Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TERLIPRESSINEpoudre | 0,85 mg · un flacon | FT |
| ACÉTATE DE TERLIPRESSINEpoudre | 1 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.